ALFA FinderBSE filing, NSE: BIBCL. Summary written from the filing by ALFA Finder's alert engine.
Bharat Immunological & Biologicals Corporation Ltd: key numbers
- Share price
- ₹9.00
- Market cap
- ₹38.86 Cr
- Revenue (annual)
- ₹44.61 Cr
- Net profit (annual)
- ₹-17.06 Cr
- P/E (TTM)
- -2.1×Sector 43.4×
- Promoter holding
- 59.25%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Other merger & restructuring announcements
All →Dabur India Merger & Restructuring
Dabur India disclosed that Atlanta Body and Health Products, a step-down subsidiary, was liquidated and closed effective 10 November 2026. No consideration or financial amount is stated.
Bondada Engineering Merger & Restructuring Worth ₹0.05 Cr
Bondada Engineering incorporated Bondada International FZ-LLC in RAKEZ, UAE, as a wholly owned subsidiary. The subscription amounts to AED 20,000, about Rs.0.05 Crore.
- Value
- ₹0.05 Cr
Deepak Fertilisers & Petrochemicals Corporation Merger & Restructuring Worth ₹0.75 Cr
Deepak Fertilisers incorporated Mahadhan Nutritek Solutions as a step-down wholly owned subsidiary on 26 October 2026. Initial subscription of Rs 0.75 Crore; no business commenced yet.
- Value
- ₹0.75 Cr
Trident Techlabs Merger & Restructuring Worth ₹1.24 Cr
Trident Techlabs incorporated a 99%-owned UAE subsidiary, Techlabs Engineering Consultancy L.L.C., in Abu Dhabi. The company subscribed AED 4.95 lakh, about Rs.1.24 Crore, for 495 shares.
- Value
- ₹1.24 Cr
Olectra Greentech Merger & Restructuring Worth ₹0 Cr
Olectra Greentech agreed to sell its 34% stake in Evey Trans (UJJ) to related party Evey Trans Private Limited for Rs 34,000. Completion is expected by February 2027.
- Value
- ₹0.00 Cr
- Execution
- Completion expected by 2027-02-09
Jubilant Ingrevia Merger & Restructuring
Jubilant Ingrevia updated on a restructuring share subscription and purchase agreement closing in two tranches. First tranche is due by November 2026, second by September 2027.
- Execution
- First tranche by November 2026; second tranche by September 2027